32 related articles for article (PubMed ID: 1394215)
1. Possibility of contribution of nucleoside transport systems to pirarubicin uptake by HL60 cells but not mononuclear cells.
Nagasawa K; Ohnishi N; Yokoyama T
Jpn J Cancer Res; 1998 Jun; 89(6):673-80. PubMed ID: 9703366
[TBL] [Abstract][Full Text] [Related]
2. Exploring novel dilazep derivatives as hENT1 inhibitors and potentially covalent molecular tools.
Dilweg MA; Gorostiola González M; de Ruiter MD; Meijboom NJ; van Veldhoven JPD; Liu R; Jespers W; van Westen GJP; Heitman LH; IJzerman AP; van der Es D
Purinergic Signal; 2024 Jun; ():. PubMed ID: 38879664
[TBL] [Abstract][Full Text] [Related]
3. Stereospecific Cross-Coupling Reactions Provide Conformationally-Biased Arylalkanes with Anti-Leukemia Activity.
Sanford AB; Tollefson EJ; Jarvo ER
Isr J Chem; 2020 Mar; 60():402-405. PubMed ID: 33442068
[TBL] [Abstract][Full Text] [Related]
4. Nucleoside transporters and immunosuppressive adenosine signaling in the tumor microenvironment: Potential therapeutic opportunities.
Kaur T; Weadick B; Mace TA; Desai K; Odom H; Govindarajan R
Pharmacol Ther; 2022 Dec; 240():108300. PubMed ID: 36283452
[TBL] [Abstract][Full Text] [Related]
5. Combination treatment with hENT1 and miR-143 reverses gemcitabine resistance in triple-negative breast cancer.
Xi Y; Li T; Xi Y; Zeng X; Miao Y; Guo R; Zhang M; Li B
Cancer Cell Int; 2022 Sep; 22(1):271. PubMed ID: 36050724
[TBL] [Abstract][Full Text] [Related]
6. Human Equilibrative Nucleoside Transporter 1 (hENT1) in Pancreatic Adenocarcinoma: Towards Individualized Treatment Decisions.
Spratlin JL; Mackey JR
Cancers (Basel); 2010 Dec; 2(4):2044-54. PubMed ID: 24281217
[TBL] [Abstract][Full Text] [Related]
7. Identification of candidate small-molecule therapeutics to cancer by gene-signature perturbation in connectivity mapping.
McArt DG; Zhang SD
PLoS One; 2011 Jan; 6(1):e16382. PubMed ID: 21305029
[TBL] [Abstract][Full Text] [Related]
8. Synthesis using ring closure metathesis and effect on nucleoside transport of a (N)-methanocarba S-(4-nitrobenzyl)thioinosine derivative.
Lee K; Cass C; Jacobson KA
Org Lett; 2001 Feb; 3(4):597-9. PubMed ID: 11178834
[TBL] [Abstract][Full Text] [Related]
9. Nucleoside transport in normal and neoplastic cells.
Belt JA; Marina NM; Phelps DA; Crawford CR
Adv Enzyme Regul; 1993; 33():235-52. PubMed ID: 8356910
[TBL] [Abstract][Full Text] [Related]
10. Nucleoside transport in animal cells.
Young JD; Jarvis SM
Biosci Rep; 1983 Apr; 3(4):309-22. PubMed ID: 6347269
[No Abstract] [Full Text] [Related]
11. A comparison of the abilities of nitrobenzylthioinosine, dilazep, and dipyridamole to protect human hematopoietic cells from 7-deazaadenosine (tubercidin).
Cass CE; King KM; Montaño JT; Janowska-Wieczorek A
Cancer Res; 1992 Nov; 52(21):5879-86. PubMed ID: 1394215
[TBL] [Abstract][Full Text] [Related]
12. Transport and metabolism of 9-beta-D-arabinofuranosylguanine in a human T-lymphoblastoid cell line: nitrobenzylthioinosine-sensitive and -insensitive influx.
Prus KL; Averett DR; Zimmerman TP
Cancer Res; 1990 Mar; 50(6):1817-21. PubMed ID: 2306735
[TBL] [Abstract][Full Text] [Related]
13. Glycine 154 of the equilibrative nucleoside transporter, hENT1, is important for nucleoside transport and for conferring sensitivity to the inhibitors nitrobenzylthioinosine, dipyridamole, and dilazep.
SenGupta DJ; Unadkat JD
Biochem Pharmacol; 2004 Feb; 67(3):453-8. PubMed ID: 15037197
[TBL] [Abstract][Full Text] [Related]
14. Changes in nucleoside transport of HL-60 human promyelocytic cells during N,N-dimethylformamide induced differentiation.
Chen SF; Cleaveland JS; Hollmann AB; Wiemann MC; Parks RE; Stoeckler JD
Cancer Res; 1986 Jul; 46(7):3449-55. PubMed ID: 3486711
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of nucleoside and nucleobase transport and nitrobenzylthioinosine binding by dilazep and hexobendine.
Plagemann PG; Kraupp M
Biochem Pharmacol; 1986 Aug; 35(15):2559-67. PubMed ID: 3741459
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
